Literature DB >> 7698574

Intestinal function and injury in acquired immunodeficiency syndrome-related cryptosporidiosis.

R W Goodgame1, K Kimball, C N Ou, A C White, R M Genta, C H Lifschitz, C L Chappell.   

Abstract

BACKGROUND/AIMS: The pathogenesis of the diarrhea in acquired immunodeficiency syndrome (AIDS)-related cryptosporidiosis is not known. The hypothesis of this study was that the intestinal dysfunction and injury are related to the number of organisms infecting the intestinal mucosa. The aim of this study was to study the influence of intensity of infection on intestinal function and injury in AIDS-related cryptosporidiosis.
METHODS: In 16 patients with AIDS with intestinal Cryptosporidium infection, the intensity of infection was quantified by counting the total number of fecal oocysts excreted in 24 hours and by determining the percent of duodenal epithelium covered by organisms. Intestinal function was assessed by vitamin B12 absorption and serum D-xylose test. Intestinal injury was assessed by morphology of duodenal mucosa, differential urinary excretion of lactulose and mannitol, and fecal alpha 1-antitrypsin clearance. Measurements were repeated after treatment with paromomycin.
RESULTS: Vitamin B12 and D-xylose absorption negatively correlated with intensity of infection. Villus atrophy occurred only in patients with oocyst excretion of > 10(8) oocyst/24 hours. Lactulose/mannitol urinary excretion ratio showed a positive correlation with intensity of infection. Intestinal function and injury improved in patients whose oocyst counts were reduced by treatment with paromomycin.
CONCLUSIONS: Cryptosporidium infection in patients with AIDS causes malabsorption and intestinal injury in proportion to the number of organisms infecting the intestine.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7698574     DOI: 10.1016/0016-5085(95)90205-8

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  30 in total

1.  Transforming growth factor beta1 is expressed in the jejunum after experimental Cryptosporidium parvum infection in humans.

Authors:  P Robinson; P C Okhuysen; C L Chappell; D E Lewis; I Shahab; S Lahoti; A C White
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

2.  Immunity to Cryptosporidium muris infection in mice is expressed through gut CD4+ intraepithelial lymphocytes.

Authors:  V McDonald; H A Robinson; J P Kelly; G J Bancroft
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

Review 3.  Management of gastrointestinal disorders in children with HIV infection.

Authors:  Alfredo Guarino; Eugenia Bruzzese; Giulio De Marco; Vittoria Buccigrossi
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

4.  Correlation between diarrhea severity and oocyst count via quantitative PCR or fluorescence microscopy in experimental cryptosporidiosis in calves.

Authors:  Darwin J Operario; Lauren S Bristol; Janice Liotta; Daryl V Nydam; Eric R Houpt
Journal:  Am J Trop Med Hyg       Date:  2014-11-04       Impact factor: 2.345

5.  Cytotoxic T cells in AIDS colonic cryptosporidiosis.

Authors:  D Reijasse; N Patey-Mariaud de Serre; D Canioni; M Huerre; E Haddad; M Leborgne; S Blanche; N Brousse
Journal:  J Clin Pathol       Date:  2001-04       Impact factor: 3.411

6.  High levels of CXCL10 are produced by intestinal epithelial cells in AIDS patients with active cryptosporidiosis but not after reconstitution of immunity.

Authors:  Heuy-Ching Wang; Sara M Dann; Pablo C Okhuysen; Dorothy E Lewis; Cynthia L Chappell; Douglas G Adler; A Clinton White
Journal:  Infect Immun       Date:  2006-10-16       Impact factor: 3.441

7.  Cryptosporidium parvum infection of human intestinal xenografts in SCID mice induces production of human tumor necrosis factor alpha and interleukin-8.

Authors:  K B Seydel; T Zhang; G A Champion; C Fichtenbaum; P E Swanson; S Tzipori; J K Griffiths; S L Stanley
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

Review 8.  Cryptosporidiosis: an emerging, highly infectious threat.

Authors:  R L Guerrant
Journal:  Emerg Infect Dis       Date:  1997 Jan-Mar       Impact factor: 6.883

9.  Expression of tumor necrosis factor alpha and interleukin 1 beta in jejuna of volunteers after experimental challenge with Cryptosporidium parvum correlates with exposure but not with symptoms.

Authors:  P Robinson; P C Okhuysen; C L Chappell; D E Lewis; I Shahab; A Janecki; A C White
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

10.  Serum immunoglobulin G, M and A response to Cryptosporidium parvum in Cryptosporidium-HIV co-infected patients.

Authors:  Kirti Kaushik; Sumeeta Khurana; Ajay Wanchu; Nancy Malla
Journal:  BMC Infect Dis       Date:  2009-11-18       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.